Utah Admin. Code R388-804-5 - Diagnostic Criteria
In diagnosing tuberculosis, health care providers shall be expected to adhere to the standards listed in this document.
(1) The Department incorporates by reference
the (IDSA/ATS/CDC) diagnostic and classification standards as described in the
segment entitled "Clinical Practice Guidelines: Diagnosis of Tuberculosis in
Adults and Children," Clinical Infectious Diseases (2016) doi:
10.1093/cid/ciw694 First published online: December 8, 2016.
(2) The Department incorporates by reference:
a) "Centers for Disease Control and
Prevention. Updated Guidelines for the Use of Nucleic Acid Amplification Tests
in the Diagnosis of Tuberculosis," MMWR 2009; 58 (01); 7-10,
b) "Centers for Disease Control and
Prevention. Availability of an Assay for Detecting Mycobacterium tuberculosis,
Including Rifampin-Resistant Strains, and Considerations for Its Use -- United
States, 2013." MMWR 2013; 62 (41), and
c) National Tuberculosis Controllers
Association/Association of Public Health Laboratories. "Consensus statement on
the use of Cepheid Xpert MTB/RIF assay in making decisions to discontinue
airborne infection isolation in healthcare settings." April
2016
(3) The Department
incorporates by reference the CDC diagnostic and classification standards for
use of Interferon Gamma Release Assays as described in the document entitled,
"Updated Guidelines for Using Interferon Gamma Release Assays to Detect
Mycobacterium tuberculosis Infection, United States, 2010" MMWR; 59 (no. RR-5);
1-25, 2010.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.